Fanigan Day Use In Pregnancy & Lactation

Pregnancy: The systemic concentration of diclofenac is lower after topical administration, compared to oral formulations. Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development.
Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If Diclofenac gel is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.
Lactation: Like other NSAIDs, diclofenac passes into breast milk in small amounts. However, at therapeutic doses of Diclofenac gel shows no effects on the suckling child are anticipated. Because of a lack of controlled studies in lactating women, the product should only be used during lactation under advice from a healthcare professional. Under this circumstance, Diclofenac gel should not be applied on the breasts of nursing mothers, nor to elsewhere on large areas of skin or for a prolonged period of time.